These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 19799199

  • 1. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA, Gendlin GE, Zhidkova DA, Tronina OA, Fedorova ND.
    Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
    [Abstract] [Full Text] [Related]

  • 2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 3. Reducing the risk of left ventricular hypertrophy in kidney transplant recipients: the potential role of mammalian target of rapamycin.
    Paoletti E, Cannella G.
    Transplant Proc; 2009; 41(6 Suppl):S3-5. PubMed ID: 19651293
    [Abstract] [Full Text] [Related]

  • 4. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E.
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [Abstract] [Full Text] [Related]

  • 5. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE, Kutyrina IM, Shvetsov MIu.
    Ter Arkh; 2012 Dec; 84(6):21-6. PubMed ID: 22997913
    [Abstract] [Full Text] [Related]

  • 6. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
    Blanchet Deverly A, Kangambega P, Hue K, Donnet JP, Merault H, Foucan L.
    Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
    [Abstract] [Full Text] [Related]

  • 7. Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis.
    Takeda A, Toda T, Iwamoto H, Watanabe K, Matsui N.
    Nephron Clin Pract; 2008 Sep; 110(2):c126-32. PubMed ID: 18931516
    [Abstract] [Full Text] [Related]

  • 8. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E, Cannella G.
    G Ital Nefrol; 2006 Sep; 23(6):560-8. PubMed ID: 17173262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Myocardial remodeling in chronic renal failure patients on hemodialysis].
    Sisakian AS, Sarkisian TsM, Petrosian ZA, Mkrtchian LG.
    Klin Med (Mosk); 2005 Sep; 83(8):68-71. PubMed ID: 16218369
    [Abstract] [Full Text] [Related]

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Sep; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 13. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C.
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [Abstract] [Full Text] [Related]

  • 14. [Left ventricular hypertrophy in patient on dialysis].
    Lovcić V, Sebetić D, Klobucić M, Kusec V.
    Acta Med Croatica; 2003 Jul; 57(1):61-4. PubMed ID: 12876866
    [Abstract] [Full Text] [Related]

  • 15. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
    Tucker B, Fabbian F, Giles M, Johnston A, Baker LR.
    Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Paoletti E, Cassottana P, Amidone M, Gherzi M, Rolla D, Cannella G.
    Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Variants of heart remodeling in essential hypertension: prevalence and determinants].
    Konradi AO, Rudomanov OG, Zakharov DV, Vakhrameeva NV, Krutikov AN, Iakovleva OI, Shliakhto EV.
    Ter Arkh; 2005 Jul; 77(9):8-16. PubMed ID: 16281481
    [Abstract] [Full Text] [Related]

  • 20. The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey.
    Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G.
    Nephrol Dial Transplant; 2004 Jul; 19(7):1829-34. PubMed ID: 15128888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.